Bernstein Initiates Coverage On AbbVie with Market Perform Rating, Announces Price Target of $203
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst Aaron Gal has initiated coverage on AbbVie (NYSE:ABBV) with a Market Perform rating and set a price target of $203.
October 17, 2024 | 11:35 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bernstein has initiated coverage on AbbVie with a Market Perform rating and a price target of $203, indicating a neutral outlook.
The Market Perform rating suggests that AbbVie's stock is expected to perform in line with the market. The price target of $203 provides a specific valuation benchmark. This neutral rating may not significantly impact the stock price in the short term, but it provides guidance for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100